1. Introduction {#s0005}
===============

Helminths are considered to be one of the most common infectious agents in humans in developing countries. Helminthiasis, an infestation of helminths in the body, is a neglected tropical disease that mostly affects people in poor countries. In addition, helminths are widely prevalent in livestock, subsequently causing losses in the agricultural sector ([@b0065]). Several studies have already reported that helminths cause long-term chronic infections in both humans and animals by regulating immune-mediated inflammation ([@b0045], [@b0050]). However, the complete eradication of helminth infection remains a distant goal, due to the lack of effective vaccines, limited pharmacological efficacy of current drugs, emerging drug resistance, and rapid reinfection in environments where transmission cannot be interrupted.

The overuses of antibiotics induce a rapid emergence of multidrug-resistant pathogens. Morbidity, mortality, the duration of hospitalization, and healthcare costs could be increase due to the antimicrobial resistance ([@b0025]). Both gram-positive bacteria including *Staphylococcus aureus* (MRSA) and multidrug-resistant (MDR) *Mycobacterium tuberculosis,* and gram-negative bacteria including extended-spectrum beta-lactamase (ESBLs)-producing bacteria, have become major global healthcare problems in the twenty-first century ([@b0105]).

For fungi infections, a few classes of antifungal drugs are available, so the emergence of resistance to single drug classes and now multidrug resistance greatly hampers patient management. Among them, *Candida* and *Aspergillus* species show increasing resistance against several drugs. Therefore drug resistance, in particular, *Candida*, is one of the greatest challenges to clinical success ([@b0110]).

Since ancient times, natural products have been used for the treatment of several infectious diseases. These products including medicinal plant extract are promising sources for the development of novel therapies against diseases ([@b0070]). The leaf extract of *Indigofera oblongifolia* is one such medicinal plant of the family *Fabaceae*, which is used for medicinal purposes due to its analgesic and anti-inflammatory properties ([@b0095]). It is also reported to have antioxidant activity and is commonly used as an antimalarial agent present in leaf active components (polyphenols, flavonoids, and organic acids) ([@b0005], [@b0035]). The present study aimed to evaluate the anthelmintic and the antimicrobial activities of ILE against the earth worm *Allolobophora caliginosa*, the yeast pathogen *Candida albicans* and gram-positive and gram-negative bacteria.

2. Materials and methods {#s0010}
========================

2.1. Preparation of the plant extract {#s0015}
-------------------------------------

*I. oblongifolia* leaves were obtained from Jazan Province in the southwest region of the Kingdom of Saudi Arabia. The identity of this species (voucher specimen number 9028) was confirmed by Dr. Pandalayil (Department of Botany and Microbiology, College of Science, King Saud University). Leaves were air dried at 40 °C and ground into a powder. The dried leaves were extracted using 70% methanol, by incubating the powder at 4 °C for 24 h with intermittent stirring. ILE was filtered and then evaporated to completely dry the sample using a vacuum evaporator (Heidolph, Germany). The dry residue was then dissolved in distilled water and used in this experiment.

To prepare ILE stock, leaves were weighed, and the percentage yield of the extraction was determined (relative to the starting dry weight of the leaves). Stock solution for the antimicrobial activity test was prepared using 100% dimethylsulfoxide (DMSO) at 25 mg/mL. The resultant solution was subsequently diluted to 12.5 mg/mL, 6.25 mg/mL, 3.125 mg/mL, and 1.56 mg/mL using 100% DMSO.

2.2. Phytochemical analysis {#s0020}
---------------------------

The amount of total phenolics and flavonoids in ILE were determined according to procedures reported by [@b0060], [@b0030], respectively.

2.3. Anthelmintic test {#s0025}
----------------------

The anthelmintic study was carried out using three doses (100, 200, and 300 mg/mL) of ILE against the earthworm *Allolobophora caliginosa* as described by [@b0010]. Briefly, eight worms of nearly the same size were treated with identical doses of ILE and subsequently the time of worm paralysis and death was determined. Time for paralysis of worms was considered as the time period to observe the absence of any sort of worm movement after worm treatment with ILE, except when the worms were shaken vigorously. Time for death of worms was recorded after ascertaining that worms neither moved when shaken vigorously nor when dipped in warm water (50 °C) followed with fading away of their body colors ([@b0010]). Albendazole suspension (10 mg/mL) was used as the reference drug in both cases (paralysis and death of worms) ([@b0080]). Distilled water was used as the negative control. All extracts and drug solutions were freshly prepared before the start of the experiment.

2.4. Microorganisms tested {#s0030}
--------------------------

The antimicrobial activity of ILE was screened against three gram-positive bacteria \[*Bacillus cereus* (ATCC 13061), *Streptococcus pneumoniae* (ATCC 27336), and *Staphylococcus aureus* (ATCC 25923)\], three gram-negative bacteria \[*Klebsiella pneumoniae* (ATCC 27736), *Pseudomonas aeruginosa* (ATCC 27853), and *Escherichia coli* (ATCC 25922)\], and the yeast strain *Candida albicans* (NCPF-3179). Test microorganisms were purchased from MediaMark Europe (Grenoble, CEDE, France) and maintained on appropriate agar plates in accordance with the manufacturer's instructions. Subsequently, colonies of each strain were resuspended in 10% glycerol, frozen, and stored at −80 °C.

2.5. Antimicrobial assay {#s0035}
------------------------

Antimicrobial activity of ILE was determined using the Kirby-Bauer disk diffusion susceptibility method ([@b0015], [@b0020]). Bacteria strains were cultured overnight on Müller--Hinton agar at 37 °C, while yeasts were cultured on Sabouraud dextrose agar at 25 °C. Suspension of each microorganism was prepared in physiological saline solution (0.9%) using the McFarland optical density of 0.5, and 200 µL of each microorganism was evenly spread on the appropriate medium using sterile cotton swabs. Disks of Whatman filter paper grade 3 were prepared using a regular paper puncher (size of disk: 6 µM) and were sterilized in an autoclave. Six dried filter paper disks were evenly distributed on the agar plates. Stock or diluents (20 µL) of leaf extract was dropped in the center of each filter paper disk (in 2 steps, each 10 µL). An equal volume of 100% DMSO was used as a negative control. The plates were left uncovered for 20 min inside a sterilized safety cabinet in order to dry the solutions. The plates were then covered and incubated at 37 °C for 24 h and 27 °C for 48 h for bacteria and yeast, respectively. After incubation, the plates were observed for the formation of a clear inhibition zone around the disk, which would be indicative of the presence of antimicrobial activity. The diameter of the zone of inhibition was measured and recorded. All experiments were done in duplicate and repeated thrice.

In order to compare the bacterial spectrum and susceptibility profile of the leaf extract of *I. oblongifolia* with commercially available antibiotics, sixteen antibiotics were selected, and the susceptibilities of the selected gram-positive and gram-negative bacteria to the antibiotics were determined. The spectrum of activity of the leaf extract was then compared with the spectrum of activity of each of these antibiotics. Among these antibiotics, the spectrum of the leaf extract showed some similarity to the spectrum of clindamycin and augmentin.

3. Results {#s0040}
==========

Pytochemical analysis revealed that phenolic and flavonoid compounds are present in the leaf extract of *I. oblongifolia* ([Fig. 1](#f0005){ref-type="fig"}). Treatment of the worms with 100 mg/ml of ILE induced worm paralysis and death significantly in comparison to the negative control, in less than 25 min and 60 min of exposure, respectively ([Table 1](#t0005){ref-type="table"}). Furthermore, increased concentration of ILE resulted in reduction of time of paralysis and death (see time of paralysis and death for the concentrations 200 mg/ml and-300 mg/ml in [table 1](#t0005){ref-type="table"}) Thus, this effect was dose dependent as increased of ILE concentration is inversely proportional to time of paralysis and death. Interestingly, the effect of higher concentrations of ILE (200 mg/ml and-300 mg/ml) on worm paralysis and death were stronger than that caused by the positive control (see time of paralysis and death Albendazole in [table 1](#t0005){ref-type="table"}).Fig. 1Total phenolic and flavonoid compounds present in ILE. Phenolic compounds were measured as mg of gallic acid equivalents per gram of the sample. Flavonoid compounds were measured as mg of quercetin equivalents per gram of the sample.Table 1Anthelminthic action of *I. oblongifolia* leaf extract.TreatmentTime to paralysis (min)Time to death (min)Vehicle control**----**ILE (100 mg/ml)23 ± 356 ± 4ILE (200 mg/ml)8.5 ± 115 ± 2ILE (300 mg/ml)6.3 ± 18.6 ± 1Albendazole (10 mg/ml)20 ± 225 ± 1[^1]

The antimicrobial activity of ILE was also assessed against gram-positive bacteria at different concentrations of the extract using the Kirby-Bauer disk diffusion susceptibility method. Estimation of the diameter of the zones of inhibition produced by serial dilutions of the leaf extract (ranging from 0.0 to 25 mg/mL) against the gram-positive bacteria tested is shown in [Fig. 2](#f0010){ref-type="fig"}. The leaf extracts of *I. oblongifolia* exhibited potent antimicrobial activity against all the gram-positive bacteria tested (*B. cereus*, *S. pneumoniae*, and *S. aureus*). The concentration of the extract was proportional to the degree of inhibition, in particular, at concentrations of 3.12, 5.25, 12.5, and 25 mg/mL ([Fig. 2](#f0010){ref-type="fig"}). These results clearly indicate that ILE has an anti-gram-positive bacterial effect.Fig. 2Antimicrobial activity of ILE against selected gram-positive bacterial pathogens: *S. pneumoniae*, *S. aureus*, and *B. cereus*. Appropriate dilutions of the leaf extract were used, and the diameter of the zone of inhibition was measured. Values are expressed as mean ± SD of three independent experiments.

Additionally, the antimicrobial activity of the leaf crude extracts from *I. oblongifolia* were tested against gram-negative bacteria -- *K. pneumoniae*, *P. aeruginosa* and *E. coli*. Interestingly, *K. pneumoniae* was highly sensitive to ILE ([Fig. 3](#f0015){ref-type="fig"}). The diameter of the zone of inhibition was also proportional to the concentration of the extract (see the diameter of zone of inhibition at 5.25, 12.5 and 25 mg/mL in [Fig. 3](#f0015){ref-type="fig"}). In contrast, the leaf extract showed no significant anti-bacterial activity against *P. aeruginosa* and *E. coli*. Thus, the leaf extract of *I. oblongifolia* is only effective against *K. pneumoniae* among the tested gram-negative bacteria.Fig. 3Antimicrobial activity of the methanolic extract of ILE against selected gram-negative bacterial pathogens: *K. pneumoniae*, *E. coli*, and *P. aeruginosa*. Dilutions similar to those used in [Fig. 2](#f0010){ref-type="fig"} were applied, and the diameter of zone of inhibition was measured.

Interestingly, the leaf extract showed greater similarity to the spectrum of chloramphenicol and cefoxitin activities (boxed in green, [Fig. 4](#f0020){ref-type="fig"}). Thus, ILE likely has a broad-spectrum of activity, which is comparable to known commercial antibiotics.Fig. 4Antimicrobial activity of common antibiotics against gram-positive and gram-negative bacteria. ILE showed close activity to chloramphenicol and cefoxitin (boxed in green). Bars are correlated to the diameter of zones of inhibition (as indicated in numbers). Values of diameters are expressed as mean ± SD of three independent experiments. All experiments were done in duplicate and repeated thrice.

Furthermore, we tested the antifungal activity of ILE against the yeast pathogen *C. albicans*. Our results for *C. albicans* showed high susceptibility to the leaf extract ([Fig. 5](#f0025){ref-type="fig"}). This inhibitory activity was even stronger than those observed against the bacterial organisms tested above. Similarly, the increase in extract concentration led to a further boost in the inhibitory activity against *C. albicans* at concentration tested ([Fig. 5](#f0025){ref-type="fig"}). These results clearly indicate that ILE acts as an antifungal compound, in particular, has considerable activity against *C. albicans*. Altogether, the results showed ILE has antimicrobial activity against gram positive bacteria, the gram-negative *K. pneumoniae*, and yeast pathogen *C. albicans* in addition to its activity as anthelmintic.Fig. 5Antimicrobial activity of the methanolic extract of ILE against the yeast pathogen *C. albicans*. Dilutions similar to those used in [Fig. 2](#f0010){ref-type="fig"} were applied, and the diameter of zone of inhibition was measured. Values are expressed as mean ± SD of three independent experiments.

4. Discussion {#s0045}
=============

The traditional treatment of nematode infections using conventional anthelmintic drugs has yielded approximately 294 million dollars in veterinary market revenue in 2004 ([@b0075]). The consequences of this are much greater than the rising costs of livestock management. There is no clear evidence that synthetic anthelmintics do not leave residues in meat, which can, in turn, pose potential public health hazards ([@b0090]). The search for novel anthelmintic plant extracts such as ILE can contribute towards the development of phytotherapeutic products that are cost effective, safe, and more accessible and offer a lower risk of resistance than the conventional therapeutic arsenal being currently employed.

In this study, ILE exhibited anthelmintic activity against *A. caliginosa* and antimicrobial activity against gram-positive bacteria, *C. albicans*, and one gram negative-bacterial strain (*K. pneumoniae*). However, there is no information reported thus far about anthelmintic activity and the antimicrobial activity of the leaf extract of *I. oblongifolia,* whereas different studies have reported the antimicrobial activities of the leaf extract of other *Indigofera* species. Our results are similar to other findings regarding the antibacterial activity of leaf extract of *I. tinctoria*, which exhibits inhibitory activity against gram-positive bacteria (*B. cereus, S. pneumoniae,* and *S. aureus*) but not against gram-negative bacteria (*P. aeruginosa*, and *E. coli*) ([@b0085]). *K. pneumoniae* and yeast were not tested in the study ([@b0085]). [@b0055] reported the antimicrobial activity of the aqueous extract of *I. dendroides* leaves against gram-positive bacteria (*S. aureus and Bacillus subtilis*), gram-negative bacteria (*K. pneumoniae* and *E. coli*), and fungal species (*Aspergillus niger* and *C. albicans*) ([@b0055]). Indeed, our and others' results are consistent with the fact that Gram-negative bacteria are more resistant to antibodies and antibiotics than Gram-positive bacteria due to the existence of the large impermeable cell wall ([@b0100]). K. pneumoniae is known as capsulated bacterium. Although the capsule of thid Gram-negative bacteria forms the major physical barrier between inside and outside of the bacterial cell, the capsule contents (lipopolysaccharide, O-antigen and lipid A) of the bacteria might serve as a target for antimicrobial compounds. For example, cationic antimicrobial peptides can disrupt the electrostatic interactions between lipid A moieties and subsequently disrupt bacterial outer membrane ([@b0040]). Our results showed that ILE is an effective anthelmintic and antibacterial agent. Further studies are required to specifically isolate the active compound(s), test broad range of pathogens and elucidate its mechanism of action.
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[^1]: Values are means ± SD. N = 8 in each group.
